Environmental risk factors for autism: an evidence-based review of systematic reviews and meta-analysesAmirhossein Modabbernia, Abraham Reichenberg|Molecular Autism|2017Cited by 793
Minocycline add-on to risperidone for treatment of negative symptoms in patients with stable schizophrenia: Randomized double-blind placebo-controlled studyShahin Akhondzadeh, Omid Mirshafiee, Bahman Salehi et al.|Psychiatry Research|2014Cited by 104
Oral Scopolamine Augmentation in Moderate to Severe Major Depressive DisorderDanial Khajavi, Shahin Akhondzadeh, Seyed-Hesammedin Abbasi et al.|The Journal of Clinical Psychiatry|2012Cited by 87
Riluzole as an Adjunctive Therapy to Risperidone for the Treatment of Irritability in Children with Autistic Disorder: A Double-Blind, Placebo-Controlled, Randomized TrialAli Ghaleiha, Shahin Akhondzadeh, Mehdi Farokhnia et al.|Pediatric Drugs|2013Cited by 70
Genome-wide analysis of a model-derived binge eating disorder phenotype identifies risk loci and implicates iron metabolismDavid Burstein, Panos Roussos, Sanan Venkatesh et al.|Nature Genetics|2023Cited by 36